Report for Diez-Iriepa D

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (8)

Title : 8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases - Knez_2023_Acta.Pharmaceutica.Sinica.B_13_2152
Author(s) : Knez D , Diez-Iriepa D , Chioua M , Gottinger A , Denic M , Chantegreil F , Nachon F , Brazzolotto X , Skrzypczak-Wiercioch A , Meden A , Pislar A , Kos J , Zakelj S , Stojan J , Salat K , Serrano J , Patricia Fernandez AP , Sanchez-Garcia A , Martinez-Murillo R , Binda C , Lopez-Munoz F , Gobec S , Marco-Contelle J
Ref : Acta Pharmaceutica Sinica B , 13 :2152 , 2023
Abstract : Knez_2023_Acta.Pharmaceutica.Sinica.B_13_2152
ESTHER : Knez_2023_Acta.Pharmaceutica.Sinica.B_13_2152
PubMedSearch : Knez_2023_Acta.Pharmaceutica.Sinica.B_13_2152
PubMedID: 37250172
Gene_locus related to this paper: human-BCHE

Title : Polyfunctionalized alpha-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment - Diez-Iriepa_2022_Antioxidants.(Basel)_11_
Author(s) : Diez-Iriepa D , Knez D , Gobec S , Iriepa I , de los Rios C , Bravo I , Lopez-Munoz F , Marco-Contelles J , Hadjipavlou-Litina D
Ref : Antioxidants (Basel) , 11 : , 2022
Abstract : Diez-Iriepa_2022_Antioxidants.(Basel)_11_
ESTHER : Diez-Iriepa_2022_Antioxidants.(Basel)_11_
PubMedSearch : Diez-Iriepa_2022_Antioxidants.(Basel)_11_
PubMedID: 36139811

Title : Studies on the affinity of 6-[(n-(cyclo)aminoalkyl)oxy]-4H-chromen-4-ones for sigma 1\/2 receptors - Deuther-Conrad_2021_RSC.Med.Chem_12_1000
Author(s) : Deuther-Conrad W , Diez-Iriepa D , Iriepa I , Lopez-Munoz F , Martinez-Grau MA , Gutschow M , Marco-Contelles J
Ref : RSC Med Chem , 12 :1000 , 2021
Abstract : Deuther-Conrad_2021_RSC.Med.Chem_12_1000
ESTHER : Deuther-Conrad_2021_RSC.Med.Chem_12_1000
PubMedSearch : Deuther-Conrad_2021_RSC.Med.Chem_12_1000
PubMedID: 34223165

Title : Tacrines as Therapeutic Agents for Alzheimer's Disease. V. Recent Developments - Bautista-Aguilera_2021_Chem.Rec_21_162
Author(s) : Bautista-Aguilera O M , Ismaili L , Iriepa I , Diez-Iriepa D , Chabchoub F , Marco-Contelles J , Perez M
Ref : Chem Rec , 21 :162 , 2021
Abstract : Bautista-Aguilera_2021_Chem.Rec_21_162
ESTHER : Bautista-Aguilera_2021_Chem.Rec_21_162
PubMedSearch : Bautista-Aguilera_2021_Chem.Rec_21_162
PubMedID: 33169934

Title : Triazolopyridopyrimidine: A New Scaffold for Dual-Target Small Molecules for Alzheimer's Disease Therapy - Zribi_2020_Molecules_25_
Author(s) : Zribi L , Pachon-Angona I , Bautista-Aguilera OM , Diez-Iriepa D , Marco-Contelles J , Ismaili L , Iriepa I , Chabchoub F
Ref : Molecules , 25 : , 2020
Abstract : Zribi_2020_Molecules_25_
ESTHER : Zribi_2020_Molecules_25_
PubMedSearch : Zribi_2020_Molecules_25_
PubMedID: 32668671

Title : New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition - Malek_2019_J.Med.Chem_62_11416
Author(s) : Malek R , Arribas RL , Palomino-Antolin A , Totoson P , Demougeot C , Kobrlova T , Soukup O , Iriepa I , Moraleda I , Diez-Iriepa D , Godyn J , Panek D , Malawska B , Gluch-Lutwin M , Mordyl B , Siwek A , Chabchoub F , Marco-Contelles J , Kiec-Kononowicz K , Egea J , de los Rios C , Ismaili L
Ref : Journal of Medicinal Chemistry , 62 :11416 , 2019
Abstract : Malek_2019_J.Med.Chem_62_11416
ESTHER : Malek_2019_J.Med.Chem_62_11416
PubMedSearch : Malek_2019_J.Med.Chem_62_11416
PubMedID: 31724859

Title : QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease Therapy - Ramos_2019_Molecules_24_
Author(s) : Ramos E , Palomino-Antolin A , Bartolini M , Iriepa I , Moraleda I , Diez-Iriepa D , Samadi A , Cortina CV , Chioua M , Egea J , Romero A , Marco-Contelles J
Ref : Molecules , 24 : , 2019
Abstract : Ramos_2019_Molecules_24_
ESTHER : Ramos_2019_Molecules_24_
PubMedSearch : Ramos_2019_Molecules_24_
PubMedID: 30999586

Title : Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy - Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
Author(s) : Pachon-Angona I , Refouvelet B , Andrys R , Martin H , Luzet V , Iriepa I , Moraleda I , Diez-Iriepa D , Oset-Gasque MJ , Marco-Contelles J , Musilek K , Ismaili L
Ref : J Enzyme Inhib Med Chem , 34 :479 , 2019
Abstract : Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
ESTHER : Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
PubMedSearch : Pachon-Angona_2019_J.Enzyme.Inhib.Med.Chem_34_479
PubMedID: 30712420